Jornal Brasileiro de Pneumologia,
Journal Year:
2024,
Volume and Issue:
unknown, P. e20240072 - e20240072
Published: July 9, 2024
Objective:
In
order
to
study
the
scenario
of
respiratory
infections
in
pediatrics
after
emergence
SARS-CoV-2
Brazil,
this
aimed
compare
characteristics
children
admitted
for
SARS
or
upper
airway
infection
caused
by
either
RSV
SARS-CoV-2.
Methods:
This
was
a
cross-sectional
involving
up
48
months
age
tertiary
pediatric
hospital
with
diagnosis
between
April
2020
and
2021.
Respiratory
secretion
samples
were
collected
2-5
days
hospitalization,
antigen/PCR
tests
viral
etiologies
performed.
analysis,
patients
laboratorial
and/or
selected,
their
clinical
epidemiological
compared
using
logistic
regression.
Results:
Our
sample
initially
comprised
369
participants.
confirmed
55
(15%)
59
(16%),
respectively.
Mean
12
(0-48
months),
47
female.
The
following
significantly
more
frequent
when
those
COVID-19:
younger
(OR
=
0.94;
95%
CI:
0.90-0.98);
lower
frequency
fever
0.18;
0.05-0.66);
symptoms:
cough
7.36;
1.04-52.25);
tachypnea
6.06;
1.31-28.0).
Conclusions:
Children
RSV-related
younger,
had
at
admission,
but
higher
signs
systemic
inflammation
hospitalized
COVID-19
during
first
year
pandemic.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(6), P. 1024 - 1024
Published: May 25, 2023
Background:
Outcomes
of
SARS
CoV-2
infection
in
infants,
children
and
young
adults
are
reported
less
frequently
than
older
populations.
The
evolution
SARS-CoV-2
cases
LA
County
youths
followed
at
a
large
health
network
southern
California
over
two
years
was
evaluated.
Methods:
A
prospective
cohort
study
patients
aged
0–24
diagnosed
with
COVID-19
conducted.
Demographics,
age
distribution,
disease
severity,
circulating
variants
concern
(VOCs),
immunization
rates
were
compared
between
first
second
pandemic
years.
Logistic
regression
estimated
odds
ratios
(OR)
95%
confidence
intervals
(CI)
factors
associated
severe/critical
COVID-19.
Results:
In
total,
61,208
tested
for
by
polymerase
chain
reaction
(PCR);
5263
positive
(8.6%)
available
data
identified
March
2020
2022.
Year
1,
5.8%
(1622/28,088)
positive,
to
11%
(3641/33,120)
2
(p
<
0.001).
Most
had
mild/asymptomatic
illness
positivity
>12%
across
all
groups
the
half
2,
when
Omicron
prevailed.
Pulmonary
higher
risk
severe
both
(OR:
2.4,
CI:
1.4–4.3,
p
=
0.002,
1;
OR:
11.3,
4.3–29.6,
Receipt
least
one
vaccine
dose
protective
against
0.3,
0.11–0.80,
0.05).
Conclusions:
Despite
different
VOCs
test
most
asymptomatic/mild
disease.
Underlying
pulmonary
conditions
increased
COVID-19,
while
vaccination
highly
youths.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(9), P. 1401 - 1401
Published: Aug. 22, 2023
This
study
aimed
to
investigate
the
associations
between
COVID-19
vaccination
status
and
self-reported
SARS-CoV-2
infection
among
children
adolescents
aged
3–17
years
during
a
massive
outbreak
after
China
changed
its
zero
COVID
policy.
A
cross-sectional
online
survey
was
conducted
1
9
March
2023.
Participants
were
parents
of
studying
in
kindergartens,
primary
schools,
or
secondary
schools
Shenzhen.
Convenient
sampling
used.
All
Longhua
District
Shenzhen
invited
attending
schools.
Interested
completed
an
survey.
Multivariate
logistic
regression
fitted.
Among
8538
participants,
40.9%
that
their
had
7
December
2022,
where
92.9%
them
received
two
doses
vaccines,
74.6%
second
dose
for
more
than
six
months.
In
multivariate
analysis,
who
no
three
months
lower
rate
compared
unvaccinated
(<1
month:
AOR:
0.17,
95%
CI:
0.07,
0.44;
1–3
months:
0.54,
0.41,
0.75).
The
duration
protection
conferred
by
series
relatively
short
children.
booster
should
be
considered
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(2), P. 211 - 211
Published: Feb. 18, 2024
The
COVID-19
pandemic
prompted
rapid
vaccine
development
and
deployment
worldwide.
Despite
widespread
vaccination
efforts,
understanding
the
effectiveness
of
vaccines
in
hospitalized
patients
remains
a
critical
concern.
This
retrospective
cohort
study,
conducted
at
tertiary
healthcare
centre
Serbia,
tracked
during
different
waves
variants—Alpha,
Delta,
Omicron.
Data
collection
included
demographics,
comorbidities,
symptoms,
status.
Among
3593
patients,
those
with
prior
exposure
to
cases
or
hospital
treatment
showed
higher
positivity
rates.
Symptom
prevalence
varied
across
waves,
coughs
persisting.
Patients
without
chronic
diseases
were
more
frequent
among
testing
negative.
Vaccine
varied,
Sinopharm
demonstrating
45.6%
initially
Pfizer-BioNTech
showing
an
up
74.8%
within
0–84
days
after
second
dose.
Mixed-dose
strategies,
notably
as
primary
dose
followed
by
booster,
suggested
increased
protection.
substantial
availability,
significant
portion
remained
unvaccinated.
study
underscores
dynamic
nature
advocates
for
booster
strategies
address
evolving
challenges
combating
COVID-19,
particularly
patients.
Jornal Brasileiro de Pneumologia,
Journal Year:
2024,
Volume and Issue:
unknown, P. e20240072 - e20240072
Published: July 9, 2024
Objective:
In
order
to
study
the
scenario
of
respiratory
infections
in
pediatrics
after
emergence
SARS-CoV-2
Brazil,
this
aimed
compare
characteristics
children
admitted
for
SARS
or
upper
airway
infection
caused
by
either
RSV
SARS-CoV-2.
Methods:
This
was
a
cross-sectional
involving
up
48
months
age
tertiary
pediatric
hospital
with
diagnosis
between
April
2020
and
2021.
Respiratory
secretion
samples
were
collected
2-5
days
hospitalization,
antigen/PCR
tests
viral
etiologies
performed.
analysis,
patients
laboratorial
and/or
selected,
their
clinical
epidemiological
compared
using
logistic
regression.
Results:
Our
sample
initially
comprised
369
participants.
confirmed
55
(15%)
59
(16%),
respectively.
Mean
12
(0-48
months),
47
female.
The
following
significantly
more
frequent
when
those
COVID-19:
younger
(OR
=
0.94;
95%
CI:
0.90-0.98);
lower
frequency
fever
0.18;
0.05-0.66);
symptoms:
cough
7.36;
1.04-52.25);
tachypnea
6.06;
1.31-28.0).
Conclusions:
Children
RSV-related
younger,
had
at
admission,
but
higher
signs
systemic
inflammation
hospitalized
COVID-19
during
first
year
pandemic.